Receptor Life Sciences

About:

Receptor Life Sciences is a biotechnology company

Top Investors: Granite Point Capital

Description:

Receptor Life Sciences provides nervous system disorders and drug-delivery technologies. They also provide oral cannabinoid products and commercialization of therapies that fill unmet medical needs.

Total Funding Amount:

$46.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2015-01-01

Founders:

Andrea Leone-Bay, Gregory F. Wesner

Number of Employees:

11-50

Last Funding Date:

2022-04-07

IPO Status:

Private

Industries: